Sai Life Sciences Share Price | Sai Life Sciences Stock Screener
SAILIFE
Pharmaceuticals
Share Price NSE
₹1131.20
▼
-9.80 (-0.86%)
Share Price BSE
₹1130.65
▼
-9.75 (-0.85%)
As of May 27, 2026, the Sai Life Sciences share price (NSE: SAILIFE) is ₹1,131.20 on NSE and ₹1,130.65 on BSE, down 0.86% from the previous close, with shares trading between ₹1,116.30 and ₹1,150.00, and a 52-week range of ₹724.05–₹1,175.90.
Check SAILIFE yearly price range for the annual price range and momentum.
Use the Sai Life Sciences stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Sai Life Sciences Market Cap
₹24,162.74 Cr.
SAILIFE P/E Ratio (TTM)
67.64
Sai Life Sciences P/B Ratio
10.06
EPS (TTM)
₹16.63
Dividend Yield
-
Debt to Equity
0.41
SAILIFE 52 Week High
₹1175.90
Sai Life Sciences 52 Week Low
₹724.05
Operating Margin
29.00%
Profit Margin
16.83%
SAILIFE Revenue (TTM)
₹618.00
EBITDA
₹192.00
Net Income
₹104.00
Total Assets
₹3,626.00
Total Equity
₹2,484.00
Sai Life Sciences Share Price Chart
Screen Sai Life Sciences share price with an interactive chart. Analyse SAILIFE price trends and volatility across different timeframes.
Sai Life Sciences Company Profile - Fundamental Screener
Screen Sai Life Sciences company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for SAILIFE shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE570L01029
Sai Life Sciences Balance Sheet Screener
Screen SAILIFE balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Total Assets | 3,626 | 3,160 | 2,275 | 2,187 | 2,157 | 1,817 | 1,410 | 1,216 |
| Current Assets | 1,411 | 1,505 | 945 | 964 | 944 | 804 | 613 | 691 |
| Fixed Assets | 2,085 | 1,488 | 1,180 | 1,037 | 751 | 701 | 641 | 374 |
| Liabilities | ||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 309 | 299 | 560 | 540 | 565 | 356 | 149 | 160 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||
| Total Equity | 2,484 | 2,128 | 975 | 888 | 879 | 863 | 794 | 720 |
| Share Capital | 21 | 21 | 18 | 18 | 18 | 18 | 16 | 16 |
| Reserves & Surplus | 2,463 | 2,108 | 957 | 870 | 861 | 845 | 777 | 703 |
Sai Life Sciences Income Statement Screener - Profit & Revenue Analysis
Screen Sai Life Sciences income statement and profit fundamentals.
Analyze SAILIFE quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Sai Life Sciences share price evaluation.
| Item | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 618 | 565 | 553 | 506 | 589 | 449 | 406 | 288 | 443 | 395 |
| Expenses | 426 | 377 | 392 | 376 | 422 | 320 | 293 | 254 | 315 | 287 |
| EBITDA | 192 | 188 | 161 | 131 | 167 | 129 | 112 | 34 | 128 | 108 |
| Operating Profit % | 29.00% | 32.00% | 27.00% | 24.00% | 27.00% | 27.00% | 26.00% | 9.00% | 28.00% | 25.00% |
| Depreciation | 45 | 44 | 40 | 38 | 38 | 34 | 36 | 31 | 31 | 31 |
| Interest | 8 | 10 | 9 | 12 | 11 | 23 | 21 | 21 | 21 | 23 |
| Profit Before Tax | 139 | 134 | 112 | 81 | 119 | 72 | 55 | -18 | 76 | 53 |
| Tax | 35 | 34 | 28 | 20 | 31 | 18 | 14 | -5 | 20 | 13 |
| Net Profit | 104 | 100 | 84 | 61 | 88 | 54 | 42 | -14 | 56 | 40 |
| EPS | 4.93 | 4.77 | 4.01 | 2.90 | 4.24 | 2.89 | 2.22 | -0.74 | 31.00 | 2.19 |
Sai Life Sciences Cash Flow Screener - Liquidity Fundamentals
Screen SAILIFE cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March |
|---|---|---|---|---|---|---|---|
| Operating Activities | 314 | 263 | 219 | 105 | -36 | 116 | 129 |
| Investing Activities | -536 | -191 | -99 | -102 | -260 | -262 | -158 |
| Financing Activities | 301 | -95 | -201 | 72 | 296 | -4 | 268 |
| Net Cash Flow | 79 | -24 | -80 | 75 | -1 | -150 | 239 |
Sai Life Sciences Shareholding Pattern Screener
See Sai Life Sciences shareholding pattern with promoter, FII, and DII holdings.
Check Sai Life Sciences promoter holding and ownership changes for SAILIFE on TickJournal.
| Item | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Jul | 2024-Sept | 2024-Dec |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 34.61% | 35.17% | 35.15% | 34.94% | 34.70% | 39.64% | 35.24% | 35.24% |
| FII Holding | 21.17% | 12.36% | 14.58% | 22.50% | 21.40% | 0.00% | 7.64% | 11.72% |
| DII Holding | 31.54% | 13.26% | 21.64% | 29.91% | 31.41% | 0.00% | 5.61% | 11.95% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 6.13% | 7.69% | 6.56% | 7.91% | 5.95% | 0.00% | 18.68% | 8.88% |
| Other Holding | 6.56% | 31.52% | 22.07% | 4.74% | 6.54% | 60.36% | 32.84% | 32.22% |
| Shareholder Count | 117,527 | 140,677 | 126,380 | 119,705 | 114,820 | 70 | 572,970 | 82 |
Sai Life Sciences Share Dividend Screener - Share Yield Analysis
Check Sai Life Sciences dividend history with payout and yield data.
View Sai Life Sciences dividend details including ex-dates and amounts for SAILIFE stock.
Sai Life Sciences Stock Index Membership
See which indices include Sai Life Sciences stock.
Check SAILIFE index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE INDEX BSE HC
BSE INDEX BSEIPO
BSE INDEX SMLCAP
NIFTY 500
NIFTY IPO
NIFTY MIDSML 400
NIFTY SMLCAP 250
NIFTY TOTAL MKT
NIFTY500 EQUAL WEIGHT
NIFTY500 MULTICAP
Sai Life Sciences Market Events Screener - Corporate Actions
Get Sai Life Sciences corporate actions including splits, bonuses, and buybacks.
Check Sai Life Sciences stock events that may affect SAILIFE share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 8.86% | ||
| 2026-05-14 | 2026-05-14 | Quarterly Result Announcement | NA | 13.13% |
| 2026-02-05 | 2026-02-05 | Quarterly Result Announcement | NA | 0.21% |
| 2025-11-06 | 2025-11-06 | Quarterly Result Announcement | NA | 3.40% |
| 2025-08-07 | 2025-08-07 | Quarterly Result Announcement | NA | -2.74% |
| 2025-05-13 | 2025-05-13 | Quarterly Result Announcement | NA | -0.61% |
| 2025-02-06 | 2025-02-06 | Quarterly Result Announcement | NA | -0.14% |
Sai Life Sciences Competitors Screener - Peer Comparison
Screen SAILIFE competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 441,670 | 40.42 | 58,220 | 6.38% | 11,565 | 54.06 |
| Divis Laboratories | 179,271 | 73.73 | 10,560 | 8.73% | 2,520 | 57.07 |
| Torrent Pharmaceuticals | 150,679 | 66.80 | 13,753 | 19.18% | 2,028 | 56.43 |
| Cipla | 114,503 | 29.26 | 27,712 | -2.46% | 3,783 | 64.74 |
| Dr Reddys Laboratories | 110,832 | 26.24 | 33,593 | -0.44% | 3,998 | 56.54 |
| Zydus Life Science | 108,578 | 20.40 | 26,720 | 13.65% | 5,242 | 74.62 |
| Lupin | 103,566 | 19.46 | 27,488 | 19.98% | 5,345 | 45.18 |
| Mankind Pharma | 100,047 | 52.84 | 14,278 | 12.03% | 1,750 | 55.67 |
| Aurobindo Pharma | 84,867 | 24.29 | 33,385 | 3.21% | 3,376 | 52.40 |
| Laurus Labs | 74,171 | 81.46 | 6,813 | 21.03% | 884 | 80.00 |
Sai Life Sciences Company Announcements - News Screener
Screen SAILIFE latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-05-24 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2026-05-19 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-15 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-05-15 | Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS | - |
| 2026-05-15 | Announcement under Regulation 30 (LODR)-Monitoring Agency Report | - |
| 2026-05-15 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-05-14 | Disclosure Of Key Performance Indicators Under SEBI (Issue Of Capital And Disclosure Requirements) Regulations 2018 | - |
| 2026-05-14 | Disclosure Of Key Performance Indicators Under SEBI (Issue Of Capital And Disclosure Requirements) Regulations 2018 | - |
| 2026-05-14 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-05-14 | Audited Financial Results For The Year Ended 31 March 2026 | - |
| 2026-05-14 | Board Meeting Outcome for Board Meeting Outcome For Approval Of Audited Financial Results For The Financial Year Ending 31.03.2026 | - |
| 2026-05-11 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-05-11 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-04-30 | Intimation Of An Order Dated 29Th April 2026 Issued By The Joint Commissioner Of Commercial Taxes (Appeals) Kalaburagi U/S 107 (11) Of The Central Goods And Services Tax Act 2017 And The Karnataka Goods And Services Tax Act 2017. | - |
| 2026-04-23 | Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS | - |
| 2026-04-21 | Board Meeting Intimation for Consideration And Approval Of Audited Financial Results (Standalone & Consolidated) For The Fourth Quarter And Year Ended 31 March 2026. | - |
| 2026-04-08 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-03-30 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-03-30 | Closure of Trading Window | - |
| 2026-03-24 | Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS | - |